Volume 31, Issue 1 p. 143

Response of pemphigus vulgaris to anti-CD20 antibody therapy (rituximab) may be delayed

A. S. Belgi

A. S. Belgi

Departments of Dermatology and Haematology, Glan Clwyd Hospital, Bodelwyddan, North Wales, LL18 5UJ, UK E-mail: [email protected]

Search for more papers by this author
M. Azeez

M. Azeez

Departments of Dermatology and Haematology, Glan Clwyd Hospital, Bodelwyddan, North Wales, LL18 5UJ, UK E-mail: [email protected]

Search for more papers by this author
C. Hoyle

C. Hoyle

Departments of Dermatology and Haematology, Glan Clwyd Hospital, Bodelwyddan, North Wales, LL18 5UJ, UK E-mail: [email protected]

Search for more papers by this author
R. E. A. Williams

R. E. A. Williams

Departments of Dermatology and Haematology, Glan Clwyd Hospital, Bodelwyddan, North Wales, LL18 5UJ, UK E-mail: [email protected]

Search for more papers by this author
First published: 28 September 2005
Citations: 30

Conflict of interest: none declared.

No abstract is available for this article.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.